MedPath

Troysetron

Brand Name: Troysetron

Generic Name: Ondansetron (as hydrochloride)

Active
Registration Number

DRP-16319

Dosage Form

Solution for Injection (IM/IV)

Issuance Date

February 4, 2025

Expiry Date

February 4, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2mg/mL
PackagingType I Clear Flint Glass Ampoule with Yellow OPC and Ring x 2mL (Box of 5's) Type I Clear Flint Glass Ampoule with Pink OPC and Ring x 4mL (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiemetic/Antinauseant (Serotonin (5HTE) antagonist]
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ondansetron (as hydrochloride)Active
Monograph: Ondansetron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform